Skip to main content

7 Result(s)

within I Soubeyran Remove this filter

and

  1. No Access

    Article

    All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth

    Gastric carcinoma is the third leading cause of cancer-related death worldwide. This cancer, most of the time metastatic, is essentially treated by surgery associated with conventional chemotherapy, and has a ...

    P H Nguyen, J Giraud, C Staedel, L Chambonnier, P Dubus, E Chevret, H Bœuf… in Oncogene (2016)

  2. No Access

    Article

    The MAP3K ZAK, a novel modulator of ERK-dependent migration, is upregulated in colorectal cancer

    Often described as a mediator of cell cycle arrest or as a pro-apoptotic factor in stressful conditions, the MAP3K ZAK (Sterile alpha motif and leucine zipper-containing kinase) has also been proven to positiv...

    C Rey, B Faustin, I Mahouche, R Ruggieri, C Brulard, F Ichas, I Soubeyran… in Oncogene (2016)

  3. No Access

    Article

    IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas

    To clarify the relationships between marginal zone lymphomas (MZLs) and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas (WM/LPLs), immunoglobulin heavy chain variable gene (IGHV) features were analyzed ...

    N Gachard, M Parrens, I Soubeyran, B Petit, A Marfak, D Rizzo, M Devesa… in Leukemia (2013)

  4. No Access

    Article

    Splenic marginal zone lymphomas and lymphoplasmacytic lymphomas originate from B-cell compartments with two different antigen-exposure histories

    M Parrens, N Gachard, B Petit, A Marfak, E Troadec, K Bouabdhalla, N Milpied… in Leukemia (2008)

  5. Article

    Open Access

    Evolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas

    Bcl-2, the gene over-expressed in follicular lymphomas (FL), is able to block chemotherapy-induced apoptosis. Consequently, we wondered whether bcl-2/IgH expression variations during treatment of FL could pred...

    P Soubeyran, I Hostein, M Debled, H Eghbali, I Soubeyran… in British Journal of Cancer (1999)

    Download PDF (444 KB)

  6. No Access

    Article

    pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients

    Tamoxifen as sole initial therapy is gaining importance in the management of post-menopausal breast cancer patients. Age oestrogen (ER) and progesterone (PR) receptor status are accurately considered to select...

    I Soubeyran, N Quénel, J-M Coindre, F Bonichon, M Durand… in British Journal of Cancer (1996)

  7. No Access

    Article

    Variation of hormonal receptor, pS2, c-erbB-2 and GSTπ contents in breast carcinomas under tamoxifen: a study of 74 cases

    Seventy-four post menopausal patients with primary non-metastatic invasive ductal carcinomas of the breast were first treated with tamoxifen alone (30 mg p.o. daily) for 5 months. To study changes induced by t...

    I Soubeyran, N Quénel, L Mauriac, M Durand, F Bonichon… in British Journal of Cancer (1996)